MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401— 510(k) K003455
Substantially EquivalentChad Therapeutics, Inc.
FDA 510(k) clearance K003455 for MODIFICATION TO CHAD THERAPEUTICS OXYMATIC MODEL 401, Substantially Equivalent on 2000-12-06. Applicant: Chad Therapeutics, Inc.. Device class: 2.
Clearance details
- Applicant
- Chad Therapeutics, Inc.
- Product code
- Code NFB
- Device class
- Class 2
- Regulation
- 21 CFR 868.5905
- Advisory panel
- Anesthesiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Chatsworth, CA, US
Recent devices under product code NFB
view allMore clearances from Chad Therapeutics, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.